and longitudinal NfL data Clene plans to analyze the APST ALS NfL biomarker and clinical dataset to compare NfL change from its ongoing NIH-sponsored EAP to address the FDA’s request for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback